Trials / Conditions / Stage III Papillary Thyroid Cancer

Stage III Papillary Thyroid Cancer

4 registered clinical trials studyying Stage III Papillary Thyroid Cancer.

Status	Trial	Sponsor	Phase
Completed	Central Neck Dissection in Patients With Clinical Node Negative Thyroid Cancer NCT02138214	University of Wisconsin, Madison	Phase 2
Terminated	Sorafenib Tosylate in Treating Patients With Locally Advanced, Metastatic, or Locally Recurrent Thyroid Cancer NCT00095693	National Cancer Institute (NCI)	Phase 2
Completed	Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Can NCT00068497	National Cancer Institute (NCI)	N/A
Completed	Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu NCT00004074	National Cancer Institute (NCI)	Phase 1